• I Am CIS
  • Post a Job on the NEW CIS Job Board

    Read More

  • CIS 2019 Annual Meeting

    Read More

  • 2019 CIS Diagnostic School in PID

    Read More

  • Your CIS Membership can begin today

    Read More

  • We are dedicated to education, research and more

    Read More

Featured Resource

JoCI February Issue

The Journal of Clinical Immunology is a bimonthly international journal that helps researchers and academic clinicians keep current on investigative basic immunology and diseases related to the immune system. This well-established journal publishes articles on basic, translational, and clinical studies in all aspects of immunology, including animal models of human diseases.


Read More

Letter from the President

Dear Colleagues:

As I enter the homestretch of my term as President of CIS, I am deeply grateful to each of you, CIS members and well-wishers, for your unstinted support and partnership these past two years, and for all the new initiatives we developed and implemented. In my first message in April 2017, I concluded my letter with a quote from Helen Keller, “Alone we can do so little; together we can do so much.” This statement reflects my experience as President of CIS. I am acutely aware of how much I owe each of you, and I know that any progress we have made, any goal achieved, has truly been a team effort, and I thank you most sincerely for coming alongside to fulfill the vision...


Read More

Tales from the Listserv

In our opinion, by enabling us to consult and ask for previous experiences from our colleagues, the CIS PIDD-Listserv is an invaluable service to us all taking care of rare immunologic disorders. 


Read More

Pioneers in Clinical Immunology

Kate Sullivan, MD, PhDDr. Kate Sullivan

"A few gender-specific thoughts are in order given the mission of this group. I have many traditional female traits. I’m a builder of consensus, I lead by example, I try to build trust and forge community. But- niceness must not be mistaken for weakness. It is possible to be simultaneously fierce, supportive, and pleasant. Maybe that is not your personality. Great!  I don’t want you to be like me. I want you to be better and to succeed by being you."


Continue Reading

Current News

Please wait while we gather your results.

X4 Pharma - Phase 3 Clincal Study

X4 Pharmaceuticals (Cambridge, MA) is planning to start a Phase 3 clinical study within the next few months, entitled “A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of mavorixafor (X4P-001) in Patients with WHIM Syndrome with Open-Label Extension”

Learn More

The CIS Foundation Represented at the 2019 Boston Marathon

CIS's very own, Liz Varga will be running on behalf of the CIS Foundation in the upcoming Boston Marathon. Support her by donating to the CIS Foundation today!

Learn More

Hyper IgM Foundation Offers $25K in Seed Grant Funding

The Hyper IgM Foundation is proud to announce the availability of $25,000 in seed grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome and primary immunodeficiency disorders. The intent of this funding is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on gene therapy/editing for CD40 Ligand Deficiency as well as hematopoietic stem cell transplantation for CD40 Ligand Deficiency. During the 2019 calendar year, the Hyper IgM Foundation will be awarding one-time grants of up to $25,000 to worthy recipients. Grant applications for 2019 grants have a submission deadline of June 30th, 2019.

Learn More

CIS Case Conference Webinar Series

CIS is pleased to provide recordings of our webinar series of immune deficiency case presentations. Hosted by the ECI Committee, this interactive electronic format emphasizes discussion of interesting cases where we can all learn from each other. Registration is free and all are welcome!


Watch Now

Next Webinar: April 23, 2019